𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group

✍ Scribed by A. CALKINS; F.B. STEHMAN; B. BUNDY; J.A. BENDA; R.S. MANNEL; P. SEAGO; F. CAPPUCCINI; R.D. ALVAREZ; B.J. MONK; M. MAIMAN

Book ID
109085643
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
57 KB
Volume
16
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of gemcitabine and doceta
Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium : A trial of the Eastern Cooperative Oncology Group
✍ Robert Dreicer; Judith Manola; Daniel J. Schneider; John F. Schwerkoske; Christo πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Gemcitabine and docetaxel are active agents in advanced urothelial carcinoma. A Phase II trial of this combination was performed to determine the activity and toxicity of these agents in a multiinstitutional setting in patients previously treated with one prior chemothera

Phase 1/2 trial of BMS-275291 in patient
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma : A multicenter trial of the AIDS Malignancy Consortium
✍ Brett T. Brinker; Susan E. Krown; Jeannette Y. Lee; Ethel Cesarman; Amy Chadburn πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND. Matrix metalloproteinases (MMPs) are overexpressed in Kaposi sarcoma (KS). The safety and efficacy of a novel, orally bioavailable MMP inhibitor, BMS‐275291, was evaluated in patients with human immunodeficiency virus‐associated KS and the correlation between changes in